Detection and Quantification of Pyrrolizidine Alkaloids in Antibacterial Medical Honeys

Abstract

In recent years, there has been an increasing interest in antibacterial honey for wound care ranging from minor abrasions and burns to leg ulcers and surgical wounds. On the other hand, several recent studies demonstrated that honey for human consumption was contaminated with natural occurring, plant derived pyrrolizidine alkaloids.

1,2-Unsaturated pyrrolizidine alkaloids are a group of secondary plant metabolites that show developmental, hepato-, and geno-toxicity as well as carcinogenic effects in animal models and in in vitro test systems. Hence, it was of particular interest to analyze the pyrrolizidine alkaloid content of medical honeys intended for wound care.

19 different medical honey samples and/or batches were analyzed by applying a recently established pyrrolizidine alkaloid sum parameter method. 1,2-Unsaturated pyrrolizidine alkaloids were converted into the common necin backbone structures and were analyzed and quantified by GC-MS in the selected ion monitoring mode.

All but one medical honey analyzed were pyrrolizidine alkaloid positive. The results ranged from 10.6 µg retronecine equivalents per kg to 494.5 µg retronecine equivalents/kg medical honey. The average pyrrolizidine alkaloid content of all positive samples was 83.6 µg retronecine equivalents/kg medical honey (average of all samples was 79.3 µg retronecine equivalents/kg medical honey). The limit of detection was 2.0 µg retronecine equivalents/kg medical honey, while the limit of quantification was 6.0 µg retronecine equivalents/kg medical honey (S/N > 7/1).

Based on the data presented here and considering the fact that medical honeys can be applied to open wounds, it seems reasonable to discuss the monitoring of 1,2-unsaturated pyrrolizidine alkaloids in honey intended for wound treatment.

Key words

pyrrolizidine alkaloids - antibacterial honey - medical honey - gas chromatography mass spectrometry

• References

• 1 FAO and WHO. Codex Alimentarius. Codex standard for honey. 1981: 1 – 8. Available at http://www.codexalimentarius.org/download/standards/310/cxs_012e.pdf Accessed October 31, 2012
• 2 Kwakman PHS, Zaat SAJ. Antibacterial components of honey. IUBMB Life 2012; 64: 48-55
• 3 Lee DS, Sinno S, Khachemoune A. Honey and wound healing. Am J Clin Dermatol 2011; 12: 181-190
• 4 Simon A, Traynor K, Santos K, Blaser G, Bode U, Molan P. Medical honey for wound care – still the ‘latest resort ?. J Evid Based Complement Alternat Med 2009; 6: 165-173
• 5 Mavric E, Wittmann S, Barth G, Henle T. Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res 2008; 52: 483-489
• 6 Adams CJ, Manley-Harris M, Molan PC. The origin of methylglyoxal in New Zealand manuka (Leptospermum scoparium) honey. Carbohydr Res 2009; 8: 1050-1053
• 7 Atrott J, Hente T. Methylglyoxal in Manuka honey correlation with antibacterial properties. Czech J Food Sci 2009; 27: 163-165
• 8 Kempf M, Reinhard A, Beuerle T. Pyrrolizidine alkaloids (PAs) in honey and pollen-legal regulation of PA levels in food and animal feed required. Mol Nutr Food Res 2010; 1: 158-168
• 9 Kempf M, Beuerle T, Bühringer M, Denner M, Trost D, von der Ohe K, Bhavanam VBR, Schreier P. Pyrrolizidine alkaloids in honey: Risk analysis by gas chromatography-mass spectrometry. Mol Nutr Food Res 2008; 10: 1193-1200
• 10 Hartmann T, Witte L. Chemistry, biology and chemoecology of the pyrrolizidine alkaloids. In: Pelletier SW, editor Alkaloids: chemical and biological perspectives, Volume 9. Oxford: Pergamon; 1995: 155-233
• 11 Fu PP, Chou MW, Churchwell M, Wang Y, Zhao Y, Xia Q, Gamboa da Costa G, Marques MM, Beland FA, Doerge DR. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of pyrrolizidine alkaloid-derived DNA adducts in vitro and in vivo . Chem Res Toxicol 2010; 3: 637-652
• 12 Gesetz über den Verkehr mit Arzneimitteln 1976; § 2.
• 13 ANZFA. Pyrrolizidine alkaloids in food: a toxicological review and risk assessment. 1 – 16. Available at http://www.foodstandards.gov.au/_srcfiles/TR2.pdf Accessed October 31, 2012
• 14 FDA. Advises dietary supplement manufacturers to remove comfrey products from the market. Available at http://www.fda.gov/Food/DietarySupplements/Alerts/ucm111219.htm Accessed October 31, 2012
• 15 Bundesanzeiger. Abwehr von Arzneimittelrisiken – Stufe II. Dtsch Apoth Ztg 1992; 132: 1406-1408
• 16 Gesetz über Medizinprodukte 1995; § 3.
• 17 EFSA. Scientific opinion on pyrrolizidine alkaloids in food and feed. EFSA Journal 2011; 11: 1-134
• 18 Kempf M, Wittig M, Reinhard A, von der Ohe K, Blacquière T, Raezke KP, Michel R, Schreier P, Beuerle T. Pyrrolizidine alkaloids in honey: comparison of analytical methods. Food Addit Contam 2011; 28: 332-347
• 19 Dübecke A, Beckh G, Lüllmann C. Pyrrolizidine alkaloids in honey and bee pollen. Food Addit Contam 2011; 28: 348-358
• 20 Fu PP, Xia Q, Lin G, Chou MW. Pyrrolizidine alkaloids – genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev 2004; 1: 1-55
• 21 Heuer D, Heuer L, Saalfrank V. Manuka-Honig. Dtsch Apoth Ztg 2011; 25: 2981-2983